Which infants should be examined with the Hammersmith Infant Neurological Examination (HINE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Who Should Be Examined with HINE

The Hammersmith Infant Neurological Examination (HINE) should be performed on all infants with newborn-detectable risk factors for cerebral palsy, including those born preterm, those with neonatal encephalopathy, those with birth defects, and all infants admitted to the NICU. 1

Primary Indications for HINE Assessment

High-Risk Populations Requiring HINE (Strong Recommendation)

The HINE is specifically indicated for infants with the following risk factors 1:

  • Preterm birth (especially <32 weeks gestational age)
  • Neonatal encephalopathy (including hypoxic-ischemic encephalopathy)
  • Birth defects
  • NICU admission for any reason
  • Abnormal neuroimaging findings (brain injury, hemorrhage, periventricular leukomalacia)

Age-Specific Applications

For infants younger than 5 months (corrected age):

  • HINE serves as an alternative when General Movements assessment or MRI are unavailable or unaffordable 1
  • HINE score <57 at 3 months is 96% predictive of cerebral palsy 1
  • This represents a strong recommendation based on moderate-quality evidence for resource-limited settings

For infants 5-24 months (corrected age):

  • HINE is recommended as part of standardized neurological assessment 1
  • HINE scores <73 at 6,9, or 12 months indicate high risk of CP 1
  • HINE scores <40 at 6,9, or 12 months almost always indicate CP 1
  • 90% predictive accuracy for CP in this age range 1

Clinical Red Flags Triggering HINE Assessment

Any infant presenting with the following should receive HINE examination 1:

  • Inability to sit independently by 9 months
  • Hand function asymmetry at any age
  • Inability to take weight through the plantar surface (heel and forefoot) of feet

Additional Clinical Applications

Beyond CP Detection

Recent evidence demonstrates HINE utility extends beyond cerebral palsy screening 2, 3:

  • Predicting cognitive delays at 2 years of age in term-born infants
  • Monitoring neurodevelopmental trajectories in high-risk populations 4
  • Assessing motor severity and prognosis in infants already diagnosed with CP 1

Severity Prediction in Diagnosed CP

For infants with confirmed or suspected CP, HINE scores predict functional outcomes 1:

  • Scores 50-73: Likely unilateral CP (95-99% will walk)
  • Scores <50: Likely bilateral CP
  • Scores 40-60: Likely GMFCS I-II (better function)
  • Scores <40: Likely GMFCS III-V (more severe impairment)

Implementation Considerations

Resource-Limited Settings

HINE is particularly valuable when advanced diagnostics are unavailable 1:

  • Serves as primary screening tool when MRI is not safe or affordable
  • Functions as alternative to General Movements assessment when specialized training is unavailable
  • Recent implementation studies in Ethiopia demonstrate feasibility in low-resource settings 5

Longitudinal Monitoring

HINE should be performed serially, not as a one-time assessment 4, 6:

  • Recommended at 3,6,9, and 12 months corrected age
  • Tracking score trajectories improves diagnostic accuracy
  • Progressive changes inform prognosis and guide intervention planning 7

Critical Caveats

  • Normal HINE scores do not exclude CP risk if other clinical concerns persist
  • Always combine HINE with clinical history and, when available, neuroimaging 1
  • In infants <2 years, severity predictions should be made cautiously as motor development is incomplete 1
  • Parent concern alone is a valid trigger for formal HINE assessment and referral 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.